Epidemiological and Operational Constraints on the Feasibility of Peste des Petits Ruminants Eradication Target by 2030: Necessity for a New Pragmatic Road Map
{"title":"Epidemiological and Operational Constraints on the Feasibility of Peste des Petits Ruminants Eradication Target by 2030: Necessity for a New Pragmatic Road Map","authors":"Kadir Yeşilbağ, Mevlüt Yaşar","doi":"10.1155/tbed/4504556","DOIUrl":null,"url":null,"abstract":"<p>Peste des petits ruminants (PPR) remains a major constraint to small ruminant production and food security, and a global eradication target for 2030 have been set by FAO/WOAH. This review analyses recent evidence on the feasibility of that target by integrating epidemiological indicators, operational performance of vaccination and surveillance systems, and structural drivers that sustain transmission. We find that the main barriers to eradication are not either virological/methodological or programmatic: achieving and sustaining high population immunity in pastoral and highly mobile systems; cold-chain and logistics constraints that reduce effective vaccine delivery; uneven surveillance sensitivity, timeliness, and data quality that limit detection of residual foci; and persistent reseeding via informal trade and transboundary movements. Multihost dynamics at wildlife–livestock interfaces, together with fragility factors such as conflict and climate-driven mobility, further complicate the endgame. Recent incursions into previously free territories highlight that progress is reversible when borders and surveillance systems are stressed. The dominance of PPR virus (PPRV) lineage IV in global spatiotemporal distribution has become increasingly evident in the last 10 years. We conclude that global freedom by 2030 is unlikely without rapid, synchronized improvements in coverage, surveillance performance, and cross-border coordination. A pragmatic pathway beyond 2030 should prioritize risk-based vaccination targeting high-connectivity corridors and markets, routine postvaccination seromonitoring as a decision trigger, strengthened endgame-grade surveillance (including targeted genomic investigation), and regional compacts that align implementation with broader resilience and economic development goals. We suggest that a new, revised global planning consisting of three consecutive phases would be more appropriate and predictable.</p>","PeriodicalId":234,"journal":{"name":"Transboundary and Emerging Diseases","volume":"2026 1","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2026-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13501124/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transboundary and Emerging Diseases","FirstCategoryId":"97","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/tbed/4504556","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Peste des petits ruminants (PPR) remains a major constraint to small ruminant production and food security, and a global eradication target for 2030 have been set by FAO/WOAH. This review analyses recent evidence on the feasibility of that target by integrating epidemiological indicators, operational performance of vaccination and surveillance systems, and structural drivers that sustain transmission. We find that the main barriers to eradication are not either virological/methodological or programmatic: achieving and sustaining high population immunity in pastoral and highly mobile systems; cold-chain and logistics constraints that reduce effective vaccine delivery; uneven surveillance sensitivity, timeliness, and data quality that limit detection of residual foci; and persistent reseeding via informal trade and transboundary movements. Multihost dynamics at wildlife–livestock interfaces, together with fragility factors such as conflict and climate-driven mobility, further complicate the endgame. Recent incursions into previously free territories highlight that progress is reversible when borders and surveillance systems are stressed. The dominance of PPR virus (PPRV) lineage IV in global spatiotemporal distribution has become increasingly evident in the last 10 years. We conclude that global freedom by 2030 is unlikely without rapid, synchronized improvements in coverage, surveillance performance, and cross-border coordination. A pragmatic pathway beyond 2030 should prioritize risk-based vaccination targeting high-connectivity corridors and markets, routine postvaccination seromonitoring as a decision trigger, strengthened endgame-grade surveillance (including targeted genomic investigation), and regional compacts that align implementation with broader resilience and economic development goals. We suggest that a new, revised global planning consisting of three consecutive phases would be more appropriate and predictable.
期刊介绍:
Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):
Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.
Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.
Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.
Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).
Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.